• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异丙醇及其代谢产物丙酮的生理药代动力学模型的建立。

Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone.

作者信息

Clewell H J, Gentry P R, Gearhart J M, Covington T R, Banton M I, Andersen M E

机构信息

The K. S. Crump Group, Inc., ICF Consulting, 602 East Georgia Avenue, Ruston, Louisiana 71270, USA.

出版信息

Toxicol Sci. 2001 Oct;63(2):160-72. doi: 10.1093/toxsci/63.2.160.

DOI:10.1093/toxsci/63.2.160
PMID:11568359
Abstract

A physiologically based pharmacokinetic (PBPK) model for isopropanol (IPA) and its major metabolite, acetone, is described. The structure of the parent chemical model, which can be used for either IPA or acetone by choosing the appropriate chemical-specific parameters, is similar to previously published models of volatile organic chemicals such as styrene. However, in order to properly simulate data on the exhalation of IPA and acetone during inhalation exposures, it was necessary to expand the description of the lung compartment to include a subcompartment for the upper respiratory tract mucus layer. This elaboration is consistent with published PBPK models of other water-soluble vapors in which the mucus layer serves to absorb the chemical during inhalation and then release it during exhalation. In the case of IPA exposure, a similar PBPK structure is used to describe the kinetics of the acetone produced from the metabolism of IPA. The resulting model is able to provide a coherent description of IPA and acetone kinetics in the rat and human for exposures to IPA by several routes: intravenous, intraperitoneal, oral, inhalation, and dermal. It is also able to consistently reproduce kinetic data for exposures of rats or humans to acetone. Thus, the model provides a validated framework for performing chemical-specific route-to-route extrapolation and cross-species dosimetry, which can be used in place of generic default calculations in support of risk assessments for IPA and acetone.

摘要

描述了一种基于生理的异丙醇(IPA)及其主要代谢产物丙酮的药代动力学(PBPK)模型。通过选择合适的化学物质特异性参数,该母体化学模型的结构可用于IPA或丙酮,其结构类似于先前发表的挥发性有机化合物(如苯乙烯)的模型。然而,为了正确模拟吸入暴露期间IPA和丙酮的呼出数据,有必要扩展肺区室的描述,以包括上呼吸道黏液层的一个子区室。这种细化与已发表的其他水溶性蒸气的PBPK模型一致,在这些模型中,黏液层在吸入过程中吸收化学物质,然后在呼出过程中释放它。在IPA暴露的情况下,使用类似的PBPK结构来描述由IPA代谢产生的丙酮的动力学。所得模型能够对大鼠和人类通过几种途径暴露于IPA时的IPA和丙酮动力学提供连贯的描述:静脉内、腹膜内、口服、吸入和经皮。它还能够一致地再现大鼠或人类暴露于丙酮时的动力学数据。因此,该模型为进行化学物质特异性的途径间外推和跨物种剂量测定提供了一个经过验证的框架,可用于代替一般的默认计算,以支持对IPA和丙酮的风险评估。

相似文献

1
Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone.异丙醇及其代谢产物丙酮的生理药代动力学模型的建立。
Toxicol Sci. 2001 Oct;63(2):160-72. doi: 10.1093/toxsci/63.2.160.
2
Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration.基于生理的异丙醇药代动力学模型在参考剂量和参考浓度推导中的应用。
Regul Toxicol Pharmacol. 2002 Aug;36(1):51-68. doi: 10.1006/rtph.2002.1540.
3
Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone.基于生理的药代动力学模型在丙酮参考剂量和参考浓度估算中的应用。
J Toxicol Environ Health A. 2003 Dec 12;66(23):2209-25. doi: 10.1080/713853996.
4
Physiologically based pharmacokinetic model for acetone.丙酮的基于生理的药代动力学模型。
Occup Environ Med. 1995 May;52(5):344-52. doi: 10.1136/oem.52.5.344.
5
Dermal absorption and pharmacokinetics of isopropanol in the male and female F-344 rat.
Drug Metab Dispos. 1998 Mar;26(3):197-202.
6
Steady-state solutions to PBPK models and their applications to risk assessment I: Route-to-route extrapolation of volatile chemicals.生理药代动力学(PBPK)模型的稳态解及其在风险评估中的应用I:挥发性化学物质的途径间外推
Risk Anal. 2006 Jun;26(3):769-80. doi: 10.1111/j.1539-6924.2006.00762.x.
7
Refinement of the oral exposure description in the cyclic siloxane PBPK model for rats and humans: Implications for exposure assessment.大鼠和人类环状硅氧烷PBPK模型中口服暴露描述的优化:对暴露评估的影响。
Toxicol Lett. 2017 Oct 20;279 Suppl 1:125-135. doi: 10.1016/j.toxlet.2017.04.002. Epub 2017 Apr 11.
8
Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors.
Inhal Toxicol. 2003 Sep;15(10):987-1016. doi: 10.1080/08958370390226350.
9
Inhalation dosimetry modeling with decamethylcyclopentasiloxane in rats and humans.大鼠和人体中十甲基环五硅氧烷的吸入剂量测定建模
Toxicol Sci. 2008 Oct;105(2):275-85. doi: 10.1093/toxsci/kfn125. Epub 2008 Jun 26.
10
Manganese tissue dosimetry in rats and monkeys: accounting for dietary and inhaled Mn with physiologically based pharmacokinetic modeling.大鼠和猴子体内锰的组织剂量测定:通过基于生理的药代动力学模型计算饮食和吸入性锰的剂量
Toxicol Sci. 2009 Mar;108(1):22-34. doi: 10.1093/toxsci/kfn264. Epub 2008 Dec 19.

引用本文的文献

1
Enabling transparent toxicokinetic modeling for public health risk assessment.实现用于公共卫生风险评估的透明毒代动力学建模。
PLoS One. 2025 Apr 16;20(4):e0321321. doi: 10.1371/journal.pone.0321321. eCollection 2025.
2
Modeling the impact of heat stress on the toxicokinetics of toluene and acetone.建立热应激对甲苯和丙酮的毒代动力学影响模型。
Arch Toxicol. 2024 Feb;98(2):471-479. doi: 10.1007/s00204-023-03646-6. Epub 2023 Dec 21.
3
Complex Mixtures: Array PBPK Modeling of Jet Fuel Components.复杂混合物:喷气燃料成分的阵列生理药代动力学建模
Toxics. 2023 Feb 17;11(2):187. doi: 10.3390/toxics11020187.
4
Evaluation of a rapid, generic human gestational dose model.快速通用的人体妊娠剂量模型评估。
Reprod Toxicol. 2022 Oct;113:172-188. doi: 10.1016/j.reprotox.2022.09.004. Epub 2022 Sep 16.
5
High-throughput PBTK models for to extrapolation.用于从到外推的高通量 PBTK 模型。
Expert Opin Drug Metab Toxicol. 2021 Aug;17(8):903-921. doi: 10.1080/17425255.2021.1935867. Epub 2021 Jun 15.
6
A Case of Liver Injury after Exposure to Isopropanol: A Challenging Diagnosis.一例异丙醇暴露后肝损伤病例:具有挑战性的诊断
GE Port J Gastroenterol. 2021 Apr;28(3):198-201. doi: 10.1159/000510035. Epub 2020 Sep 16.
7
Development and evaluation of a high throughput inhalation model for organic chemicals.高通量有机化学物吸入模型的开发与评估。
J Expo Sci Environ Epidemiol. 2020 Sep;30(5):866-877. doi: 10.1038/s41370-020-0238-y. Epub 2020 Jun 16.
8
Translational research to develop a human PBPK models tool kit-volatile organic compounds (VOCs).开发用于挥发性有机化合物(VOCs)的人 PBK 模型工具包的转化研究。
J Toxicol Environ Health A. 2012;75(1):6-24. doi: 10.1080/15287394.2012.625546.
9
Physiologically based pharmacokinetic modeling: methodology, applications, and limitations with a focus on its role in pediatric drug development.基于生理的药代动力学建模:方法、应用及局限性,重点关注其在儿科药物研发中的作用
J Biomed Biotechnol. 2011;2011:907461. doi: 10.1155/2011/907461. Epub 2011 Jun 1.
10
A mathematical model for breath gas analysis of volatile organic compounds with special emphasis on acetone.一种用于挥发性有机化合物呼吸气体分析的数学模型,特别侧重于丙酮。
J Math Biol. 2011 Nov;63(5):959-99. doi: 10.1007/s00285-010-0398-9. Epub 2011 Jan 14.